The utility of methacholine airway responsiveness measurements in evaluating anti-asthma drugs

Journal of Allergy and Clinical Immunology

Volumn 101, Issue 3, 1998, Pages 342-348

  Inman, Mark D ^a,b   Hamilton, Alan L ^a   Kerstjens, Huib A M ^a   Watson, Rick M ^a   O'Byrne, Paul M ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b Health Science Center   (Canada)

Author keywords

Airway responsiveness; Allergen; Asthma; Bronchoprotection; Reproducibility

Indexed keywords

ANTIASTHMATIC AGENT; METHACHOLINE; SALBUTAMOL;

ARTICLE; ASTHMA; BRONCHODILATATION; BRONCHUS REACTIVITY; CLINICAL ARTICLE; DIAGNOSTIC VALUE; HUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; TREATMENT OUTCOME;

EID: 0031895435     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70246-5     Document Type: Article

References (35)

1. Hargreave FE, Dolovich J, O'Byme PM, Ramsdale EH, Daniel EE. The origin of airway hyperresponsiveness. J Allergy Clin Immunol 1986;78:825-32.
2. Dautebande L, Philippot E. Crise d'asthme experimental par aerosis de carbaminocholine chez l'homme. Presse Med 1941:49:942-6.
3. Yan K, Salome C, Woolcock AJ. Rapid method for measurement of bronchial responsiveness. Thorax 1983;38:760-5.
4. Cockcroft DW, Killian DN, Mellon JJA, Hargreave FE, Mellon JJ. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977;7:235-43.
5. Juniper EF, Frith PA, Dunnett C, Cockcroft DW, Hargreave FE. Reproducibility and comparison of responses to inhaled histamine and methacholine. Thorax 1978;33:705-10.
6. Dehaut P, Raichielle A, Martin RR, Malo JL. Histamine dose-response curves in asthma: reproducibility and sensitivity of different indices to assess response. Thorax 1983:38:516-22.
7. Esau S, del Carpio J, Martin JG. A comparison of the effects of ketotifen and clemastine on cutaneous and airway reactivity to histamine and allergen in atopic asthmatic subjects. J Allergy Clin Immunol 1984;74:270-4.
8. Maconochie JG, Denyer LH, Hassani H. Dose-related protection against histamine-induced bronchoconstriction by inhaled salmeterol. Int J Clin Pharmacol Ther 1994;32:329-34.
9. Rabe KF, Jorres R, Nowak D, Behr N, Magnussen H. Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma. Am Rev Respir Dis 1993:147:1436-41.
10. Altounyan REC. Changes in histamine and atropine responsiveness as a guide to diagnosis and evaluation of therapy in obstructive airway disease. In: Pepys J, Frankland AW, editors. Disodium cromoglycate in allergic airways disease. Edinborough: Butter-worths; 1970. p. 47.
11. Cockcroft DW, Ruffin RE, Dolovich J, Hargreave FE. Allergen-induced increase in non-allergic bronchial reactivity. Clin Allergy 1977;7:503-13.
12. Brusasco V, Crimi E, Gianiorio P, Lantero S, Rossi GA. Allergen-induced increase in airway responsiveness and inflammation in mild asthma. J Appl Physiol 1990;69:2209-14.
13. Woolley KL, Adelroth E, Woolley MJ, Ellis R, Jordana M, O'Byrne PM. Effects of allergen challenge on eosinophils, eosinophil cationic protein and granulocyte-macrophage colony stimulating factor in mild asthma. Am J Respir Crit Care Med 1995;151:1915-24.
14. Freitag A, Watson RM, Matsos G, Eastwood C, O'Byme PM. Effect of a platelet activating factor antagonist, WEB 2086, on allergen induced asthmatic responses. Thorax 1993;48:594-8.
15. Cockcroft DW, McParland CP, Britto SA, Swystun VA, Rutherford BC. Regular inhaled salbutamol and airway responsiveness to allergen. Lancet 1993;342:833-7.
16. Ward AJ, McKenniff M, Evans JM, Page CP, Costello JF. Theophylline - An immunomodulatory role in asthma? Am Rev Respir Dis 1993;147:518-23.
17. Pavord ID, Wong CS, Williams J, Tattersfleld AE. Effect of inhaled prostaglandin E2 on allergen-induced asthma. Am Rev Respir Dis 1993;148:87-90.
18. Twentyman OP, Finnerty JP, Holgate ST. The inhibitory effect of nebulized albuterol on the early and late asthmatic reaction and increase in airway responsiveness provided by inhaled allergen in asthma. Am Rev Respir Dis 1991;144:782-7.
19. Cockcroft DW, McParland CP, O'Byme PM, Manning PJ, Friend JL, Rutherford BC, et al. Beclomethasone given after the early asthmatic response inhibits the late response and the increased methacholine responsiveness. J Allergy Clin Immunol 1993;91:1163-8.
20. Taylor IK, O'Shaughnessy KM, Fuller RW, Dollery CT. Effect of cysteinyl leukotriene receptor antagonist ICI 204,219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet 1991;337:690-4.
21. Diamant Z, Timmers MC, van der Veen H, Friedman BS, De Smet M, Depre M, et al. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo. J Allergy Clin Immunol 1995;95:42-51.
22. Kirby JG, Hargreave FE, Cockcroft DW, O'Byme PM. Effect of indomethacin on allergen-induced asthmatic responses. J Appl Physiol 1989;66:578-83.
23. Inman MD, Watson R, Cockcroft DW, Wong BJ, Hargreave FE, O'Byme PM. Reproducibility of allergen-induced early and late asthmatic responses. J Allergy Clin Immunol 1995;95:1191-5.
24. Morris JF, Koski A, Johnson LC. Spirometric standards for healthy nonsmoking adults. Am Rev Respir Dis 1971; 103:57-67.
25. National Heart, Lung, and Blood Institute; National Institutes of Health; U.S. Department of Health. Guidelines for the diagnosis and management of asthma. US Department of Health and Human Services; 1991. Publication No. 91-3042
26. Juniper EF, Cockcroft DW, Hargreave FE. Histamine and methacholine inhalation tests: tidal breathing method. Laboratory procedure and standardisation. 2nd ed. Lund, Sweden: Astra Draco AB; 1994.
27. Cockcroft DW, Murdock KY, Kirby J, Hargreave FE. Prediction of airway responsiveness to allergen from skin sensitivity to allergen and airway responsiveness to histamine. Am Rev Respir Dis 1987; 135:264-7.
28. Streiner DL, Norman GR. Reliability. In: Streiner DL, Norman GR, editors. Health measurement scales. Oxford: Oxford University Press; 1989. p. 79-96.
29. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307-10.
30. Kupper LL, Hafner KB. How appropriate are popular sample size formulas? Am Statistician 1989;43:101-5.
31. Cockcroft DW, Murdock KY. Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. J Allergy Clin Immunol 1987;79:734-40.
32. Crimi N, Palermo F, Oliveri R, Vancheri C, Polosa R, Palermo B, et al. Comparative study of the effects of nedocromil sodium (4 mg) and sodium cromoglycate (10 mg) on adenosine-induced bronchoconstriction in asthmatic subjects. Clin Allergy 1988;18:367-74.
33. Hamilton AL, Watson RM, Wylie G, O'Byme PM. A 5-lipoxygenase activation protein antagonist, Bay X 1005 attenuates both early and late phase allergen-induced bronchoconstriction in asthmatic subjects. Thorax 1997;52:348-54.
34. Hendeles L, Harman E, Huang D, O'Brien R, Blake K, Delafuente J. Theophylline attenuation of airway responses to allergen: comparison with cromolyn metered-dose inhaler. J Allergy Clin Immunol 1995;95:505-14.
35. Manning PJ, Stevens WH, Cockcroft DW, O'Byme PM. The role of thromboxane in allergen-induced asthmatic responses. Eur Respir J 1991;4:667-72.